81 related articles for article (PubMed ID: 7828668)
1. O6-benzylguanine increases the sensitivity of human primary bone marrow cells to the cytotoxic effects of temozolomide.
Fairbairn LJ; Watson AJ; Rafferty JA; Elder RH; Margison GP
Exp Hematol; 1995 Feb; 23(2):112-6. PubMed ID: 7828668
[TBL] [Abstract][Full Text] [Related]
2. Depletion of O6-alkylguanine-DNA alkyltransferase correlates with potentiation of temozolomide and CCNU toxicity in human tumour cells.
Baer JC; Freeman AA; Newlands ES; Watson AJ; Rafferty JA; Margison GP
Br J Cancer; 1993 Jun; 67(6):1299-302. PubMed ID: 8512814
[TBL] [Abstract][Full Text] [Related]
3. O6-benzylguanine potentiates the in vivo toxicity and clastogenicity of temozolomide and BCNU in mouse bone marrow.
Chinnasamy N; Rafferty JA; Hickson I; Ashby J; Tinwell H; Margison GP; Dexter TM; Fairbairn LJ
Blood; 1997 Mar; 89(5):1566-73. PubMed ID: 9057638
[TBL] [Abstract][Full Text] [Related]
4. O6-benzylguanine enhances the sensitivity of a glioma xenograft with low O6-alkylguanine-DNA alkyltransferase activity to temozolomide and BCNU.
Wedge SR; Newlands ES
Br J Cancer; 1996 May; 73(9):1049-52. PubMed ID: 8624262
[TBL] [Abstract][Full Text] [Related]
5. Protection of mammalian cells against chloroethylating agent toxicity by an O6-benzylguanine-resistant mutant of human O6-alkylguanine-DNA alkyltransferase.
Hickson I; Fairbairn LJ; Chinnasamy N; Dexter TM; Margison GP; Rafferty JA
Gene Ther; 1996 Oct; 3(10):868-77. PubMed ID: 8908500
[TBL] [Abstract][Full Text] [Related]
6. Effect of single and multiple administration of an O6-benzylguanine/temozolomide combination: an evaluation in a human melanoma xenograft model.
Wedge SR; Porteous JK; Newlands ES
Cancer Chemother Pharmacol; 1997; 40(3):266-72. PubMed ID: 9219512
[TBL] [Abstract][Full Text] [Related]
7. O6-Benzylguanine potentiates BCNU but not busulfan toxicity in hematopoietic stem cells.
Westerhof GR; Down JD; Blokland I; Wood M; Boudewijn A; Watson AJ; McGown AT; Ploemacher RE; Margison GP
Exp Hematol; 2001 May; 29(5):633-8. PubMed ID: 11376877
[TBL] [Abstract][Full Text] [Related]
8. Chemoprotective gene transfer I: transduction of human haemopoietic progenitors with O6-benzylguanine-resistant O6-alkylguanine-DNA alkyltransferase attenuates the toxic effects of O6-alkylating agents in vitro.
Hickson I; Fairbairn LJ; Chinnasamy N; Lashford LS; Thatcher N; Margison GP; Dexter TM; Rafferty JA
Gene Ther; 1998 Jun; 5(6):835-41. PubMed ID: 9747464
[TBL] [Abstract][Full Text] [Related]
9. Effect of O6-benzylguanine analogues on sensitivity of human tumor cells to the cytotoxic effects of alkylating agents.
Dolan ME; Mitchell RB; Mummert C; Moschel RC; Pegg AE
Cancer Res; 1991 Jul; 51(13):3367-72. PubMed ID: 1647266
[TBL] [Abstract][Full Text] [Related]
10. Relationships among cell survival, O6-alkylguanine-DNA alkyltransferase activity, and reactivation of methylated adenovirus 5 and herpes simplex virus type 1 in human melanoma cell lines.
Maynard K; Parsons PG; Cerny T; Margison GP
Cancer Res; 1989 Sep; 49(17):4813-7. PubMed ID: 2547518
[TBL] [Abstract][Full Text] [Related]
11. Activity of temozolomide against human tumor colony-forming units.
Raymond E; Izbicka E; Soda H; Gerson SL; Dugan M; Von Hoff DD
Clin Cancer Res; 1997 Oct; 3(10):1769-74. PubMed ID: 9815562
[TBL] [Abstract][Full Text] [Related]
12. Chemoprotective gene transfer II: multilineage in vivo protection of haemopoiesis against the effects of an antitumour agent by expression of a mutant human O6-alkylguanine-DNA alkyltransferase.
Chinnasamy N; Rafferty JA; Hickson I; Lashford LS; Longhurst SJ; Thatcher N; Margison GP; Dexter TM; Fairbairn LJ
Gene Ther; 1998 Jun; 5(6):842-7. PubMed ID: 9747465
[TBL] [Abstract][Full Text] [Related]
13. Influence of O6-methylguanine on DNA damage and cytotoxicity of temozolomide in L1210 mouse leukemia sensitive and resistant to chloroethylnitrosoureas.
Taverna P; Catapano CV; Citti L; Bonfanti M; D'Incalci M
Anticancer Drugs; 1992 Aug; 3(4):401-5. PubMed ID: 1421437
[TBL] [Abstract][Full Text] [Related]
14. Protection of committed murine haemopoietic progenitors against BCNU toxicity does not predict protection of primitive, multipotent spleen colony-forming cells - implications for chemoprotective gene therapy.
Chinnasamy N; Rafferty J; Lashford L; Chinnasamy D; Margison G; Thatcher N; Dexter T; Fairbairn L
Leukemia; 1999 Nov; 13(11):1776-83. PubMed ID: 10557052
[TBL] [Abstract][Full Text] [Related]
15. Macrophage inflammatory protein 1alpha attenuates the toxic effects of temozolomide in human bone marrow granulocyte-macrophage colony-forming cells.
Clemons M; Watson A; Howell A; Chang J; Heyworth C; Lord B; Testa N; Dexter TM; Margison G
Clin Cancer Res; 2000 Mar; 6(3):966-70. PubMed ID: 10741722
[TBL] [Abstract][Full Text] [Related]
16. O6-(4-bromothenyl)guanine reverses temozolomide resistance in human breast tumour MCF-7 cells and xenografts.
Clemons M; Kelly J; Watson AJ; Howell A; McElhinney RS; McMurry TB; Margison GP
Br J Cancer; 2005 Nov; 93(10):1152-6. PubMed ID: 16278661
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of O6-alkylguanine DNA-alkyltransferase or poly(ADP-ribose) polymerase increases susceptibility of leukemic cells to apoptosis induced by temozolomide.
Tentori L; Orlando L; Lacal PM; Benincasa E; Faraoni I; Bonmassar E; D'Atri S; Graziani G
Mol Pharmacol; 1997 Aug; 52(2):249-58. PubMed ID: 9271347
[TBL] [Abstract][Full Text] [Related]
18. Inactivation of O6-alkylguanine-DNA alkyltransferase in human peripheral blood mononuclear cells by temozolomide.
Lee SM; Thatcher N; Crowther D; Margison GP
Br J Cancer; 1994 Mar; 69(3):452-6. PubMed ID: 8123472
[TBL] [Abstract][Full Text] [Related]
19. In vivo depletion of O6-alkylguanine-DNA-alkyltransferase in lymphocytes and melanoma of patients treated with CB 10-277, a new DTIC analogue.
Lee SM; Thatcher N; Crowther D; Margison GP
Cancer Chemother Pharmacol; 1992; 31(3):240-6. PubMed ID: 1464162
[TBL] [Abstract][Full Text] [Related]
20. In vitro inactivation of human O6-alkylguanine DNA alkyltransferase by antitumor triazene compounds.
Lacal PM; D'Atri S; Orlando L; Bonmassar E; Graziani G
J Pharmacol Exp Ther; 1996 Oct; 279(1):416-22. PubMed ID: 8859021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
